Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor

Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor

US Patent 11304952 · Granted Apr 19, 2022

Estimated economic value: $47,084,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Floating chair2025
Cyclic compounds as receptor modulating therapeutics and methods and uses thereo2025
TGF-β inhibitors2025
Method of treating focal segmental glomerulosclerosis2025
Method of treating focal segmental glomerulosclerosis2025
Method of treating focal segmental glomerulosclerosis2025
Substituted-N-heteroaryl compounds and uses thereof2024
2-oxindole compounds2024
LED display screen2024
Head-up display screen, head-up display assembly, and vehicle2024
Substituted-pyridinyl compounds and uses thereof2024
Light-shielding frame and LED display device2024